{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:10:47Z","timestamp":1778659847015,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>A class of beta-lactam antibiotics known as carbapenems is\nused as a last option to treat serious bacterial infections that are resistant to multiple\ndrugs. However, the fast rise of Carbapenem-Resistant Organisms (CROs), a serious\nthreat to world health, is a result of the overuse and misuse of these antibiotics. Acinetobacter\nbaumannii and Pseudomonas aeruginosa have been linked to treatment failure\nrates of about 40-60% in severe infections, with fatality rates as high as 60% in carbapenem-\nresistant A. baumannii (CRAB)-associated pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review systematically analyzes recent literature (2010-2024) on the application\nof carbapenem, the development of different carbapenem resistances, the mechanism\nof action, and evaluates nanotechnology-based strategies to solve the carbapenem\nresistance problem.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Nanotechnology-based techniques could offer a solution to this global problem.\nNanoparticle-antibiotic combinations have higher antibacterial activity than free antibiotics\nalone. Significant decreases in MIC (Minimum Inhibitory Concentration) and\nMBC (Minimum Bactericidal Concentration) values, improved bactericidal kinetics, a\nwider zone of inhibition, and strong synergistic interactions were found. Nanocarriers efficiently\nshielded carbapenems from enzymatic degradation, increased intracellular delivery,\nand damaged bacterial membranes via a variety of processes, including reactive oxygen\nspecies (ROS) formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This systematic review attempts to provide an in-depth analysis of carbapenem\nresistance with the most recent data in order to assess the role and effect of this combined\ndrug-nanostructure to combat carbapenem resistance. Additionally, it examines\nand emphasizes preclinical research that treats Multidrug-Resistant (MDR) bacterial infections\nby combining nanomaterials with antibiotics. By highlighting the benefits of the\nenhanced antibacterial and antibiofilm qualities and offering a workable plan for combating\ncarbapenem-resistant bacteria, this review significantly contributes to a new understanding\nof biomedical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Nanotechnology-based carbapenem delivery systems are a potent and diverse\ntechnique for combating carbapenem resistance. Preclinical investigations have\nfound that employing nanotechnology to treat carbapenem beta-lactam resistance is particularly\nbeneficial. Nanomaterial-based techniques provide unique and effective solutions\nto the growing antibiotic resistance dilemma by utilizing multi-modal mechanisms\nof action that bypass standard bacterial defense routes. Drug-nanoparticle conjugation\nimproves antibacterial activity, lowers resistance development, and provides a realistic\nmethod to extend the therapeutic life of carbapenem antibiotics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673434450260429063103","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:37Z","timestamp":1778657557000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addressing Carbapenem Beta-Lactam Resistance by Nanotechnology"],"prefix":"10.2174","volume":"33","author":[{"given":"Moupiya","family":"Ghosh","sequence":"first","affiliation":[{"name":"Department of Basic Science &amp; Humanities, Office of the Sustainability. Institute of Engineering and Management(IEM), University of Engineering and Management, Newtown, Kolkata, West Bengal, 700160, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal Krishna","family":"Banik","sequence":"additional","affiliation":[{"name":"College of Sciences and Human Studies, Deanship of Research, Prince Mohammad Bin Fahd University,Al Khobar, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673434450260429063103","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253695\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673434450260429063103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:47Z","timestamp":1778657567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253695\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673434450260429063103","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}